These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 31346605)

  • 41. The Lack of Synergy between Carvedilol and the Preventive Effect of Dexrazoxane in the Model of Chronic Anthracycline-Induced Cardiomyopathy.
    Szponar J; Ciechanski E; Ostrowska-Lesko M; Gorska A; Tchorz M; Dabrowska A; Dudka J; Murias M; Kowalczyk M; Korga-Plewko A; Mandziuk S
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Doxorubicin-induced delayed-onset subclinical cardiotoxicity in mice.
    Desai VG; Vijay V; Han T; Moland CL; Phanavanh B; Lee T; Davis KJ; Muskhelishvili L; Stine KC; Fuscoe JC
    J Appl Toxicol; 2022 May; 42(5):778-792. PubMed ID: 34668590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
    Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
    Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protective Effects of a Novel Agonist of Galanin Receptors Against Doxorubicin-Induced Cardiotoxicity in Rats.
    Studneva I; Palkeeva M; Veselova O; Molokoedov A; Ovchinnikov M; Sidorova M; Pisarenko O
    Cardiovasc Toxicol; 2019 Apr; 19(2):136-146. PubMed ID: 30238355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Appraising cardiotoxicity associated with liposomal doxorubicin by means of tissue Doppler echocardiography end-points: rationale and design of the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue Doppler imaging Evaluation) randomized pilot study.
    Lotrionte M; Palazzoni G; Natali R; Comerci G; Abbate A; Di Persio S; Biondi-Zoccai GG
    Int J Cardiol; 2009 Jun; 135(1):72-7. PubMed ID: 18572266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin.
    Pouna P; Bonoron-Adèle S; Gouverneur G; Tariosse L; Besse P; Robert J
    Cancer Chemother Pharmacol; 1995; 35(3):257-61. PubMed ID: 7805186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice.
    Shizukuda Y; Matoba S; Mian OY; Nguyen T; Hwang PM
    Mol Cell Biochem; 2005 May; 273(1-2):25-32. PubMed ID: 16013437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice.
    Bruynzeel AM; Abou El Hassan MA; Schalkwijk C; Berkhof J; Bast A; Niessen HW; van der Vijgh WJ
    Br J Cancer; 2007 Mar; 96(6):937-43. PubMed ID: 17325706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes.
    Working PK; Newman MS; Sullivan T; Yarrington J
    J Pharmacol Exp Ther; 1999 May; 289(2):1128-33. PubMed ID: 10215696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Doxorubicin triggers splenic contraction and irreversible dysregulation of COX and LOX that alters the inflammation-resolution program in the myocardium.
    Jadapalli JK; Wright GW; Kain V; Sherwani MA; Sonkar R; Yusuf N; Halade GV
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1091-H1100. PubMed ID: 30074834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Testosterone Antagonizes Doxorubicin-Induced Senescence of Cardiomyocytes.
    Altieri P; Barisione C; Lazzarini E; Garuti A; Bezante GP; Canepa M; Spallarossa P; Tocchetti CG; Bollini S; Brunelli C; Ameri P
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26746999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention.
    Henriksen PA
    Heart; 2018 Jun; 104(12):971-977. PubMed ID: 29217634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity.
    Fan GC; Zhou X; Wang X; Song G; Qian J; Nicolaou P; Chen G; Ren X; Kranias EG
    Circ Res; 2008 Nov; 103(11):1270-9. PubMed ID: 18948619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of membrane-associated calcium-independent phospholipase A2 as a potential culprit of anthracycline cardiotoxicity.
    Swift L; McHowat J; Sarvazyan N
    Cancer Res; 2003 Sep; 63(18):5992-8. PubMed ID: 14522926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease.
    Ferreira de Souza T; Quinaglia A C Silva T; Osorio Costa F; Shah R; Neilan TG; Velloso L; Nadruz W; Brenelli F; Sposito AC; Matos-Souza JR; Cendes F; Coelho OR; Jerosch-Herold M; Coelho-Filho OR
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1045-1055. PubMed ID: 30092965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sulforaphane protects the heart from doxorubicin-induced toxicity.
    Singh P; Sharma R; McElhanon K; Allen CD; Megyesi JK; Beneš H; Singh SP
    Free Radic Biol Med; 2015 Sep; 86():90-101. PubMed ID: 26025579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management.
    Iarussi D; Indolfi P; Casale F; Martino V; Di Tullio MT; Calabrò R
    Paediatr Drugs; 2005; 7(2):67-76. PubMed ID: 15871628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiac safety of liposomal anthracyclines.
    Ewer MS; Martin FJ; Henderson C; Shapiro CL; Benjamin RS; Gabizon AA
    Semin Oncol; 2004 Dec; 31(6 Suppl 13):161-81. PubMed ID: 15717742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune response proteins as predictive biomarkers of doxorubicin-induced cardiotoxicity in breast cancer patients.
    Yu LR; Cao Z; Makhoul I; Daniels JR; Klimberg S; Wei JY; Bai JP; Li J; Lathrop JT; Beger RD; Todorova VK
    Exp Biol Med (Maywood); 2018 Feb; 243(3):248-255. PubMed ID: 29224368
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity.
    Jing X; Yang J; Jiang L; Chen J; Wang H
    Cell Physiol Biochem; 2018; 48(2):692-704. PubMed ID: 30025410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.